← Back to Search

Local Anesthetic

Right sided catheter normal saline and left sided catheter bupivacaine 0.25% for Postoperative Pain

Phase 4
Waitlist Available
Led By Brian M Ilfeld, MD,MS
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up postoperative day 2 (00:01 through afternoon data-collection time point)
Awards & highlights

Study Summary

This study is evaluating whether a catheter and infusion of local anesthetic can increase the duration of the effects of a single-injection ESP block.

Eligible Conditions
  • Postoperative Pain
  • Surgical Incisions
  • Acute Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day of surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and day of surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
"Average" pain during postoperative day 1 as measured using the numeric rating scale, collected postoperative day 1 for the time since midnight. This is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale
Secondary outcome measures
"Average" pain during postoperative day 2 which is the "average" pain measured using the numeric rating scale, collected postoperative day 2 for the time since midnight. This is a 0-10 Likert scale measuring pain level with 0 = no pain and 10=worst pain
"Average" pain during postoperative day 3 which is the "average" pain measured using the numeric rating scale, collected postoperative day 3 for the time since midnight. It is a 0-10 Likert scale measuring pain level with 0=no pain and 10=worst pain
"Current" pain during postoperative days 1-3 which is the current pain experienced using the numeric rating scale, collected postoperative days 1-3. This is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain
+7 more
Other outcome measures
Antiemetic use
Hospital length of stay
Indication for surgery
+10 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Right sided catheter normal saline and left sided catheter bupivacaine 0.25%Experimental Treatment2 Interventions
This is a split body study. Bilateral erector spinae plane catheters will be inserted and study fluid is administered bilaterally. Normal saline will be administered through the right-sided catheter while bupivacaine 0.25% will be administered through the left-sided catheter. Both infusion pumps will be programmed to deliver a basal infusion of 1 mL/h and an automatic intermittent bolus of 20 mL every 4 hours.
Group II: Right sided catheter bupivacaine 0.25% and left sided catheter normal salineExperimental Treatment2 Interventions
This is a split body study. Bilateral erector spinae plane catheters will be inserted and study fluid is administered bilaterally. Bupivacaine 0.25 will be administered through the right-sided catheter while normal saline will be administered through the left-sided catheter. Both infusion pumps will be programmed to deliver a basal infusion of 1 mL/h and an automatic intermittent bolus of 20 mL every 4 hours.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine 0.25%
2016
Completed Phase 4
~950
Normal Saline
2019
Completed Phase 4
~1770

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,407 Total Patients Enrolled
6 Trials studying Postoperative Pain
401 Patients Enrolled for Postoperative Pain
Brian M Ilfeld, MD,MSPrincipal InvestigatorUCSD Medical Center
1 Previous Clinical Trials
138 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025